Sophisticated and simple
Overview of ESMO Therapeutic Landscapes 2026 The ESMO Therapeutic Landscapes webinar series returns in 2026 with a focused session on the toxicity and safety considerations…

Overview: A New Mechanism Behind Immunotherapy Resistance in Kidney Cancer Immunotherapy has transformed the treatment landscape for advanced renal cell carcinoma (RCC), but responses remain…

A new approach targets solid tumors Chimeric antigen receptor (CAR) T cell therapy has transformed the treatment landscape for certain blood cancers, but solid tumors—such…
